Skip to content
by Legal Desire
SIGN IN GO PRO
Lawyer profile

Jeffrey Scharfstein

DLA Piper
Claim this profile
Firm
DLA Piper
Practice
Not stated
Office
Austin
Active in the record
2022 to 2026

Deal experience

Deal types
M&A
Sectors
Healthcare & Life SciencesTechnology
Jurisdictions
AustraliaIrelandIsraelUnited States

Deals

5 announced deals in the record
DLA Piper advises Silicon Laboratories in US$7.5 billion acquisition by Texas Instruments 10 Feb 2026
M&A Technology DLA Piper USD 7.50bn Austin
DLA Piper advises PROS Holdings in its acquisition by Thoma Bravo for $1.4 billion 6 Oct 2025
M&A Technology DLA Piper USD 1.40bn Lead Austin
DLA Piper advises SolarWinds in its acquisition by Turn/River for $4.4 billion 12 Feb 2025
M&A Technology DLA Piper USD 4.40bn Lead Austin
DLA Piper advises Alimera Sciences in acquisition by ANI Pharmaceuticals 16 Jul 2024
M&A Healthcare & Life Sciences DLA Piper USD 381m Lead
DLA Piper advises Lionheart III Corp on the first de-SPAC transaction with an Australian public company 5 Aug 2022
M&A Technology DLA Piper USD 360m
Deal alerts PRO

Get an email when Jeffrey Scharfstein is named on a newly announced deal.

See Pro plans

Alerts come as one daily email at most.

Pro

Analytics for Jeffrey Scharfstein

The paid plans add analytics for this lawyer, and for every firm and lawyer in the database:

  • Complete deal history, filtered by keyword, deal type, sector and year
  • Deals by year, sector and deal type
  • Frequent co-counsel and the firms most often on the other side
  • Repeat clients, as named in the announcements
  • CSV and Excel export
SEE PLANS SIGN IN
Is this you?

Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.

Claim this profile

Suggest a correction